DeepMed Research

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Study to Understand Risk and Resilience Opportunity for Newborns After Delivery

Not Applicable

Active, not recruiting

Conditions: A. Longitudinal Cohort N=400
B. Lower Risk (n=45) and Higher Risk (n=105) Randomized 2:1 to PERCCS Intervention

First Posted Date: 2020-06-18

Last Posted Date: 2025-03-18

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 105

Registration Number: NCT04438161

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

Remote Collection of Patient Reported Toxicity Using SMS Text Messaging (CareSignal)

Completed

Conditions: Cancer

Interventions: Other: CareSignal

First Posted Date: 2020-06-18

Last Posted Date: 2021-08-25

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 30

Registration Number: NCT04437472

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

ADAPT for Adolescents Adolescents

Not Applicable

Active, not recruiting

Conditions: HIV/AIDS

Interventions: Behavioral: SOC-REC/CCT
Behavioral: SOC-REC/IP-NAV
Behavioral: SOC-REC/SOC-OIC
Behavioral: E-NAV/CCT
Behavioral: E-NAV/SOC-OIC
Behavioral: E-Nav/IP-NAV

First Posted Date: 2020-06-16

Last Posted Date: 2024-06-17

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 880

Registration Number: NCT04432571

Locations: 🇰🇪
Kenya Medical Research Institute, Kisumu, Kenya

Core Warming of COVID-19 Patients

Not Applicable

Withdrawn

Conditions: COVID 19

Interventions: Device: ensoETM device

First Posted Date: 2020-06-11

Last Posted Date: 2020-10-19

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT04426344

Locations: 🇺🇸
Barnes-Jewish Hospital, Saint Louis, Missouri, United States

Coronavirus Smell Therapy for Anosmia Recovery

Phase 2

Withdrawn

Conditions: Anosmia

Interventions: Drug: Budesonide
Behavioral: High-Concentration Essential Oil
Drug: Placebo
Behavioral: Low-Concentration Essential Oil

First Posted Date: 2020-06-09

Last Posted Date: 2021-03-02

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT04422275

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

Diffusion Basis Spectrum Imaging of the Prostate

Not Applicable

Recruiting

Conditions: Prostate Cancer

Interventions: Device: MRI with DBSI analysis

First Posted Date: 2020-06-09

Last Posted Date: 2024-07-16

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 500

Registration Number: NCT04420702

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Needs of Persons with Spinal Cord Injury (SCI)

Completed

Conditions: Spinal Cord Injuries

First Posted Date: 2020-06-09

Last Posted Date: 2025-03-28

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 53

Registration Number: NCT04422769

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Intravenous Thyroxine for Heart-Eligible Organ Donors

Phase 3

Completed

Conditions: Brain Death
Heart Failure

Interventions: Drug: Thyroxine
Drug: Saline

First Posted Date: 2020-06-04

Last Posted Date: 2024-01-10

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 838

Registration Number: NCT04415658

Locations: 🇺🇸
Lifesharing, San Diego, California, United States
🇺🇸
Texas Organ Sharing Alliance, San Antonio, Texas, United States
🇺🇸
Mid-America Transplant Services, Saint Louis, Missouri, United States

and more 11 locations

Cabozantinib in High Grade Neuroendocrine Neoplasms

Phase 2

Recruiting

Conditions: High Grade Neuroendocrine Neoplasms

Interventions: Drug: Cabozantinib
Procedure: Blood for plasma biomarkers
Procedure: Tissue biopsy

First Posted Date: 2020-06-02

Last Posted Date: 2025-05-15

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 32

Registration Number: NCT04412629

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Moxidectin for LF, Cote d'Ivoire (DOLF)

Phase 3

Active, not recruiting

Conditions: Lymphatic Filariasis

Interventions: Drug: Ivermectin
Drug: Albendazole
Drug: Moxidectin
Drug: Diethylcarbamazine

First Posted Date: 2020-06-01

Last Posted Date: 2023-10-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 164

Registration Number: NCT04410406

Locations: 🇨🇮
Regional Hospital of Agboville, Southern Cote d'Ivoire, Agboville, Côte D'Ivoire

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy